ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

COMPARATIVEANALYSISOFSOFAVS.SAPS-IISCORE IN ASSESSING MORTALITY IN POLYTRAUMA PATIENTS FOR QUALITY MANAGEMENT

Journal: International Journal of Advanced Research (Vol.11, No. 10)

Publication Date:

Authors : ; ;

Page : 471-479

Keywords : ;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Background: The rise in severe combined traumas, underscores the need for accurate trauma assessment. The urgency to determine diagnoses and treatments for a variety of bodily injuries and disorders in polytrauma cases highlights the necessity for a robust classification system to evaluate trauma severity. Thus, the study aimed to assess the predictive value of the SOFA and SAPS II systems in evaluating mortality among polytrauma patients. Materials and Methodology: In this single centre prospective study, a total of 200 patients with injuries in at least two regions and an ISS > 16 were included. Demographic information and variables for SOFA and SAPS II calculations were recorded upon admission. SOFA scores were applied to evaluate organ failure, with variables assessed at different time points to provide comprehensive insights. SAPS II scores were derived using established procedures, considering vital signs, blood tests, and Glasgow Coma Scale (GCS) values. Mortality outcomes were monitored for up to 30 days post-admission. Result: The relationship between SOFA and SAPS II scores was significant, with a Chi-square value and p-value less than 0.001. Notably, elevated SOFA scores were linked to reduced survival rates, as affirmed by a substantial Chi-square association between SOFA scores and survival outcomes (Chi-square: 116.80, p < 0.001). The ROC Curve analysis with SOFAs AUROC at 0.924 and SAPS IIs AUROC at 0.99. SAPS II exhibited superior sensitivity and a lower false negative rate compared to SOFA. Conclusion: SOFA score effectively assesses organ dysfunction over time, while SAPS II excel in prognostic accuracy with an AUROC of 0.99, superior sensitivity, and reduced false negatives. SAPS II emerge as the more precise outcome predictor, aiding clinical decisions for enhanced patient care and improved outcomes in critical settings.

Last modified: 2023-11-10 18:42:03